| |
|
|
| |
| 投稿时间： 2015-03-19 最后修改时间： 2015-07-14 摘要点击次数: 2620 全文下载次数: 1882 |
| |
| 引用本文：杨男, 田燕, 宋浩伟,等.我国低价药品目录的品种及价格分析[J].中国卫生政策研究,2015,8(8):44-50 |
|
| 杨男1, 田燕1, 宋浩伟2, 宋民宪3, 彭亮4, 胡明1 |
1. 四川大学华西药学院, 四川成都 610041;
2. 北京市中伦文德律师事务所成都分所, 四川成都 610017;
3. 四川省药学会, 四川成都 610041;
4. 雅安职业技术学院附属医院, 四川雅安 625000 |
| 基金项目:国家自然科学基金(71473170);四川大学青年教师科研启动基金(2014SCU11069) |
| |
|
| | 摘要:目的:分析低价药品政策可能产生的影响及实施过程中存在的问题。方法:检索国家食品药品监督管理总局等相关网站,收集低价药品清单中相关药品说明书;计算全国各省2009年1月-2014年8月不同企业品种中标价格对应的最高日均药品费用、最低日均药品费用等指标。结果:(1)低价药品清单中包含533种通用名药品,和基本药物品种的重合率为51.59%;97.56%的低价药品种纳入国家医保目录。(2)不同企业生产的同种药品中标价格对应的最高日均药品费用和最低日均药品费用的差值为0.01元~30.96元;89.1%的西药品种剂型低于限价标准。(3)不同低价药品生产企业中标价的日均药品费用差为0.01元~19.35元;92.13%的中成药品种低于限价标准。讨论:低价药品清单纳入品种缺乏严谨论证;低价药品定价的合理性和效果尚需验证;低价药品价格管理政策与其他政策的衔接仍需明确。 | |
|
|
关键词:低价药品 药品中标价格 日均药品费用 基本药物 医保目录
|
| |
| Price and varieties of low-price medicine list in China |
| YANG Nan1, TIAN Yan1, SONG Hao-wei2, SONG Min-xian3, PENG Liang4, HU Ming1 |
1. West China School of Pharmacy, Sichuan University, Chengdu Sichuan 610041, China;
2. ChengDu Substation of Zhonglun W & D Law Firm, Chengdu Sichuan 610017, China;
3. Sichuan Pharmaceutical Association, Chengdu Sichuan 610041, China;
4. Yoann Professional Technology Institute Affiliated Hospital, Ya'an Sichuan 625000, China |
| |
|
| | Abstract:Objective: This paper aims to analyze the related effects of the low price medicine policy, and problems in the implementation process. Methods: To retrieve an official website of the state food and medicine supervision and administration, collect the package supplements of the low-price medicines and analyze their varieties according to their situations, and calculate he highest and lowest average daily use indicators for the medicine, etc. from January 2009 to August 2014. Results: (1) The low-price medicine list contains 533 kinds of standard medicines, and the coincidence rate with the essential medicines list is 51.59%. Results also show that 96.82% of the low-price medicines are incorporated into the national medical insurance directory. (2) The daily medicine cost difference of the maximum and minimum bidder price to the same medicine produced by different manufacturers ranges from 0.01 to 30.96 Yuan with 94.76% of the western medicine dosage constituting the existing price rise space. (3) The daily medicine cost difference ranges from 0.01 to 19.35 Yuan with 92.13% of the proprietary Chinese medicine varieties constituting the existing price rise space. Discussions: The low-price medicine varieties lack in the strict proof, the fact of low pricing the medicine has a two-way effect, and the connection between the low-price medicine administration policy and other policies is unclear. | |
|
|
|
|
